CasLoc logo
All Cases PTAB Litigations UPC Oppositions

NAUTILUS NEUROSCIENCES, INC. v. EDICT PHARMACEUTICALS PVT. LTD.

2:11-cv-04183

Overview

Case Number 2:11-cv-04183
Filing Date 2011-07-20
Status Terminated
Termination Date 2012-09-26
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

EDICT PHARMACEUTICALS PVT. LTD. Operating Company

Represented By

3 Attorneys Listed

JEFFREY S. SOOS

SAIBER LLC

Tel: +1 (973) 622-3333

SAIBER LLC, ONE GATEWAY CENTER

ARNOLD B. CALMANN

SAIBER LLC

Tel: +1 (973) 622-3333
Fax: +1 (973) 622-3349

SAIBER LLC, ONE GATEWAY CENTER

KATHERINE ANN ESCANLAR

SAIBER LLC

Tel: +1 (973) 622-3333

SAIBER LLC, ONE GATEWAY CENTER

Plaintiff

NAUTILUS NEUROSCIENCES, INC. Operating Company

Represented By

6 Attorneys Listed

THOMAS J. MELORO , JR.

WILLKIE FARR & GALLAGHER LLP

Tel: +1 (212) 728-8000

787 SEVENTH AVENUE, NEW YORK, NY 10019-6099

RUKHSANAH L. SINGH

CONNELL FOLEY LLP

85 LIVINGSTON AVENUE, ROSELAND, NJ 07068

LIZA M. WALSH

CONNELL FOLEY, LLP

Tel: +1 (973) 535-0500

85 LIVINGSTON AVENUE, ROSELAND, NJ 07068

MELISSA BETH BERGER

WILLKIE FARR & GALLAGHER LLP

Tel: +1 (212) 728-8595

787 SEVENTH AVENUE, NEW YORK, NY 10019

KETAN PASTAKIA

WILLKIE FARR & GALLAGHER LLP

Tel: +1 (212) 728-8713

787 SEVENTH AVENUE, NEW YORK, NY 10019

JESSICA L. PALMER

CONNELL FOLEY LLP

Tel: +1 (973) 535-0500

85 LIVINGSTON AVENUE, ROSELAND, NJ 07068

Counter Claimant

PAR PHARMACEUTICAL COMPANIES, INC. Operating Company

Represented By

1 Attorneys Listed

ERIC ADAM BIDERMAN

ARENT FOX LLP

Tel: +1 (212) 484-3900
Fax: +1 (212) 484-3990

1675 BROADWAY, NEW YORK, NY 10019

Counter Defendant

APR APPLIED PHARMA RESEARCH SA Operating Company

Represented By

6 Attorneys Listed

THOMAS J. MELORO , JR.

WILLKIE FARR & GALLAGHER LLP

Tel: +1 (212) 728-8000

787 SEVENTH AVENUE, NEW YORK, NY 10019-6099

RUKHSANAH L. SINGH

CONNELL FOLEY LLP

85 LIVINGSTON AVENUE, ROSELAND, NJ 07068

LIZA M. WALSH

CONNELL FOLEY, LLP

Tel: +1 (973) 535-0500

85 LIVINGSTON AVENUE, ROSELAND, NJ 07068

MELISSA BETH BERGER

WILLKIE FARR & GALLAGHER LLP

Tel: +1 (212) 728-8595

787 SEVENTH AVENUE, NEW YORK, NY 10019

KETAN PASTAKIA

WILLKIE FARR & GALLAGHER LLP

Tel: +1 (212) 728-8713

787 SEVENTH AVENUE, NEW YORK, NY 10019

JESSICA L. PALMER

CONNELL FOLEY LLP

Tel: +1 (973) 535-0500

85 LIVINGSTON AVENUE, ROSELAND, NJ 07068

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 8 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (8): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6974595
Pharmaceutical compositions based on Diclofenae
Filed: 2000-03-14
Issued: 2005-12-13
Expired (Term Ended)
Expires: 2020-03-14
US7482377
Pharmaceutical compositions and methods of treatment based on diclofenac
Filed: 2005-05-18
Issued: 2009-01-27
Expired (Term Ended)
Expires: 2017-08-18
US7759394
Diclofenac formulations and methods of use
Filed: 2006-06-16
Issued: 2010-07-20
Expired (Term Ended)
Expires: 2026-06-16
US8097651
Diclofenac formulations and methods of use
Filed: 2010-01-07
Issued: 2012-01-17
Active (3.1 yrs remaining)
Expires: 2030-01-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

12

Dispositive

0

Granted

4

Denied

0

Pending / Review

6

Motions by Category

Procedural / Extension Motion 4 Claim Construction / Markman Filing 8

Key Dispositive Motions & Rulings

Procedural / Extension Motion Granted
ORDER granting 65 Motion for Leave to Appear Pro Hac Vice for Aparnaa Bhatt Saini and Colman B. Ragan, Esq. Signed by Magistrate Judge Cathy L. Waldor on 9/18/1...
Entry #66 • 2012-09-18 Document →
Procedural / Extension Motion Granted
MOTION for Leave to Appear Pro Hac Vice by APR APPLIED PHARMA RESEARCH SA, NAUTILUS NEUROSCIENCES, INC.. (Attachments: # 1 Certification of Liza M. Walsh, # 2 C...
Entry #65 • 2012-09-17 Document →
Claim Construction / Markman Filing Pending / Under Review
LETTER ORDER scheduling a Markman Hearing on 11/8/2012 at 11:00 AM before Judge Esther Salas, and that for the purposes of discussing the schedule for the day o...
Entry #64 • 2012-09-13 Document →
Claim Construction / Markman Filing Pending / Under Review
MARKMAN RESPONSE BRIEF re 56 Markman Opening Brief, (Attachments: # 1 Declaration of Keith J. Miller, Esq. In Support of Defendants' Responsive Claim Constructi...
Entry #60 • 2012-08-17 Document →
Claim Construction / Markman Filing Pending / Under Review
MARKMAN OPENING BRIEF of Defendants Wockhardt USA LLC, Wockhardt Ltd. and Edict Pharmaceuticals Pvt. Ltd. (now known as Par Formulations Pvt. Ltd.) (Attachments...
Entry #57 • 2012-07-03 Document →
Claim Construction / Markman Filing Granted
ORDER granting request that the 3/2/12 Amended Scheduling Order be further amended extending the deadline for the parties to file their respective Opening Claim...
Entry #55 • 2012-06-27 Document →

Docket Entries

(77 total)
Pleading / Complaint

COMPLAINT against EDICT PHARMACEUTICALS PVT. LTD. ( Filing fee $ 350 receipt number 3839880.) NONE., filed by NAUTILUS NEUROSCIENCES, INC., APR APPLIED PHARMA RESEARCH SA. (Attachments: # 1 Form AO 120, # 2 Summons, # 3 Civil Cover Sheet)(ld, ) (Entered: 07/25/2011)

Entry #1 • 2011-07-20
1
Pleading / Complaint

COMPLAINT against EDICT PHARMACEUTICALS PVT. LTD. ( Filing fee $ 350 receipt number 3839880.) NONE., filed by NAUTILUS NEUROSCIENCES, INC., APR APPLIED PHARMA RESEARCH SA. (Attachments: # 1 Form AO 120, # 2 Summons, # 3 Civil Cover Sheet)(ld, ) (Entered: 07/25/2011)

Entry #1 • 2011-07-20
2
Pleading / Complaint

COMPLAINT against EDICT PHARMACEUTICALS PVT. LTD. ( Filing fee $ 350 receipt number 3839880.) NONE., filed by NAUTILUS NEUROSCIENCES, INC., APR APPLIED PHARMA RESEARCH SA. (Attachments: # 1 Form AO 120, # 2 Summons, # 3 Civil Cover Sheet)(ld, ) (Entered: 07/25/2011)

Entry #1 • 2011-07-20
2
Pleading / Complaint

COMPLAINT against EDICT PHARMACEUTICALS PVT. LTD. ( Filing fee $ 350 receipt number 3839880.) NONE., filed by NAUTILUS NEUROSCIENCES, INC., APR APPLIED PHARMA RESEARCH SA. (Attachments: # 1 Form AO 120, # 2 Summons, # 3 Civil Cover Sheet)(ld, ) (Entered: 07/25/2011)

Entry #1 • 2011-07-20
2

Corporate Disclosure Statement by APR APPLIED PHARMA RESEARCH SA, NAUTILUS NEUROSCIENCES, INC. identifying NONE as Corporate Parent.. (ld, ) (Entered: 07/25/2011)

Entry #2 • 2011-07-20
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc